scholarly journals Evaluation of retinoblastoma (Rb) and protein-53 (p53) gene expression levels in breast cancer cell lines (MCF-7) induced with some selected cytotoxic plants

2013 ◽  
Vol 5 (7) ◽  
pp. 120-126 ◽  
Author(s):  
Titilola Aderonke Samuel ◽  
Ayorinde Babatunde James ◽  
Temitope Adesola Oshodi ◽  
Uchennaya Okereke Odii ◽  
Innocent Chidume ◽  
...  
2013 ◽  
Vol 47 (4) ◽  
pp. 382-389 ◽  
Author(s):  
Nina Trost ◽  
Tina Stepisnik ◽  
Sabina Berne ◽  
Anja Pucer ◽  
Toni Petan ◽  
...  

AbstractBackground. Functional erythropoietin (EPO) signaling is not specific only to erythroid lineages and has been confirmed in several solid tumors, including breast. Three different isoforms of erythropoietin receptor (EPOR) have been reported, the soluble (EPOR-S) and truncated (EPOR-T) forms acting antagonistically to the functional EPOR. In this study, we investigated the effect of human recombinant erythropoietin (rHuEPO) on cell proliferation, early gene response and the expression of EPOR isoforms in the MCF-7 breast cancer cell line.Materials and methods. The MCF-7 cells were cultured with or without rHuEPO for 72 h or 10 weeks and assessed for their growth characteristics, expression of early response genes and different EPOR isoforms. The expression profile of EPOR and EPOR-T was determined in a range of breast cancer cell lines and compared with their invasive properties.Results. MCF-7 cell proliferation after rHuEPO treatment was dependent on the time of treatment and the concentration used. High rHuEPO concentrations (40 U/ml) stimulated cell proliferation independently of a preceding long-term exposure of MCF-7 cells to rHuEPO, while lower concentrations increased MCF-7 proliferation only after 10 weeks of treatment. Gene expression analysis showed activation of EGR1 and FOS, confirming the functionality of EPOR. rHuEPO treatment also slightly increased the expression of the functional EPOR isoform, which, however, persisted throughout the 10 weeks of treatment. The expression levels of EPOR-T were not influenced. There were no correlations between EPOR expression and the invasiveness of MCF-7, MDA-MB-231, Hs578T, Hs578Bst, SKBR3, T-47D and MCF-10A cell lines.Conclusions. rHuEPO modulates MCF-7 cell proliferation in time- and concentration-dependent manner. We confirmed EGR1, FOS and EPOR as transcription targets of the EPO-EPOR signaling loop, but could not correlate the expression of different EPOR isoforms with the invasiveness of breast cancer cell lines.


2020 ◽  
Vol 11 (2) ◽  
pp. 9157-9169

Breast cancer is the most common cancer among women. Chemotherapy is one of the main methods of breast cancer treatment, but its efficacy is affected by drug resistance. Interleukin-1 receptor-dependent kinases (IRAKs) are associated with drug resistance in cancer cells. The aim of this study was to investigate the relationship between the expression of p53, Bax, Bcl-2, and GALANT14 in treatment with Methotrexate and Topotecan alone and in combination with IRAK1/4 inhibitor. BT20, BT549, and MB468 breast cancer cell lines were cultured in a specific culture medium, and the effects of Methotrexate and Topotecan with or without IRAK1/4 inhibition on the expression of P53, Bcl-2, Bax, and GALNT14 genes was evaluated by Real-Time PCR. RT-qPCR results showed that the administration of IRAK1/4 inhibitor increased the expression of p53 in all three cell lines treated with Methotrexate and Topotecan. IRAK1/4 inhibitor increased the efficacy of Methotrexate and Topotecan on p53 gene expression. The expression level of the Bcl2 gene was significantly increased in the MB468 cell line treated with Topotecan and IRAK inhibitor + Methotrexate. In the present study, it was found that the IRAK1/4 inhibitor increased the efficacy of Methotrexate and Topotecan on p53 gene expression, thereby inducing apoptosis.


2018 ◽  
Vol 16 (Special Issue) ◽  
pp. 15-22
Author(s):  
Wei Boon Yap ◽  
Shaktypreya Nadarajah ◽  
Nadiah Shidik ◽  
Noorjahan Banu Mohammed Alitheen

Phytomedicine ◽  
2015 ◽  
Vol 22 (1) ◽  
pp. 153-157 ◽  
Author(s):  
M.S. Camargo ◽  
M.T. Oliveira ◽  
M.M. Santoni ◽  
F.A. Resende ◽  
A.P. Oliveira-Höhne ◽  
...  

2018 ◽  
Vol 8 (3) ◽  
pp. 159 ◽  
Author(s):  
Meghan Fragis ◽  
Abdulmonem I. Murayyan ◽  
Suresh Neethirajan

Background: Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer deaths among Canadian women. Cancer management through changes in lifestyle, such as increased intake of foods rich in dietary flavonoids, have been shown to decrease the risk associated with breast, liver, colorectal, and upper-digestive cancers in epidemiologic studies. Onions are high in flavonoid content and one of the most common vegetables. Additionally, onions are used in most Canadian cuisines.Methods: We investigated the effect of five prominent Ontario grown onion (Stanley, Ruby Ring, LaSalle, Fortress, and Safrane) extracts on two subtypes of breast cancer cell lines: a triple negative breast cancer line MDA-MB-231 and an ER+ breast cancer line MCF-7.Results: These onion extracts elicited strong anti-proliferative, anti-migratory, and cytotoxic activities on both the cancer cell lines. Flavonoids present in these onion extracts induced apoptosis, cell cycle arrest in the G2/M phase, and a reduction in mitochondrial membrane potential at dose-dependent concentrations. Onion extracts were more effective against MDA-MB-231 compared to the MCF-7 cell line. Conclusion: In this study, we investigated the extracts synthesized from Ontario-grown onion varieties in inducing anti-migratory, cytostatic, and cytotoxic activities in two sub-types of human breast cancer cell lines. Anti-tumor activity of these extracts depends upon the varietal and can be formulated into nutraceuticals and functional foods for the wellbeing of cancer patients. Overall, the results suggest that onion extracts are a good source of flavonoids with anti-cancerous properties.Keywords: onion extracts; flavonoids; anti-proliferative; breast cancer; cytotoxic activity


2000 ◽  
Vol 2 (S1) ◽  
Author(s):  
CJ Pogson ◽  
CMW Chan ◽  
L-A Martin ◽  
GPH Gui ◽  
M Dowsett

Sign in / Sign up

Export Citation Format

Share Document